All interested persons are provided 60 days from the above date to comment on this safety assessment and to identify
additional published data that should be included or provide unpublished data which can be made public and included.
Information may be submitted without identifying the source or the trade name of the cosmetic product containing the
ingredient. All unpublished data submitted to CIR will be discussed in open meetings, will be available at the CIR office for
review by any interested party and may be cited in a peer-reviewed scientific journal. Please submit data, comments, or
requests to the CIR Director, Dr. Lillian J. Gill.
The 2015 Cosmetic Ingredient Review Expert Panel members are: Chair, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V.
Belsito, M.D.; Ronald A. Hill, Ph.D.; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; James G. Marks, Jr., M.D.; Ronald
C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and Paul W. Snyder, D.V.M., Ph.D. The CIR Director is Lillian J. Gill, D.P.A.
This report was prepared by Lillian C. Becker, Scientific Analyst/Writer.
The Cosmetic Ingredient Review (CIR) Expert Panel (Panel) has previously concluded that many of the individual
constituents that make up alkyl taurate amides and taurate salts, (ie, the alcohol and/or the acid), are safe as used in
cosmetics.2-10 Because the safety of the individual constituents may be relevant to the safety of the ester, Table 2 provides the
conclusions reported previously for those individual components. Although the individual constituents are relevant to the
safety of the alkyl taurate amides and taurate salts, the available data are well-documented in the existing CIR reports and
will not be summarized here; however, the maximum reported concentration of use is provided. The cocoyl moiety is
derived from the fatty acid of coconut acid, which is composed of various amounts of caproic acid, caprylic acid, capric acid,
lauric acid, linoleic acid, myristic acid, oleic acid, palmitoleic acid, and stearic acid. The Panel has reviewed coconut oil,
oleyl myristate, stearyl caprylate, stearyl palmitate, lauric acid, myristic acid, oleic acid and concluded that these ingredients
were safe as used (Table 2). Linoleic acid has not been reviewed by the Panel. Background information is provided on
taurine. However, since taurine is ubiquitous in high concentrations throughout the animal kingdom, including in humans,
additional toxicity data are not necessary.
A comprehensive search of the literature identified little published data relevant to this safety assessment. No
toxicity data have been submitted by industry. However, pertinent data were discovered in the European Chemicals Agency
(ECHA) database.11-13 Information from the summaries presented in the ECHA database are presented in this safety
assessment.
CHEMISTRY
Definition and Structure
The ingredients in this report, the alkyl taurate amides and taurate salts, are all structurally related by having the
same taurate core (Figure 1). The ingredients vary by N-substitution and by the identity of the counter-ion to the sulfonate
functional group. For instance, potassium taurate, sodium methyltaurate, and sodium taurate vary by either hydrogen or
methyl N-substitution, and either sodium or potassium counter-ions.
The remaining ingredients in this report bear a fatty acyl N-substitution which forms, together with taurate, an amide
(ie, alkyl taurate amide; Figure 2). These alkyl taurate amides share the same taurate core, and vary by fatty chain length and
counter ion. While some of the ingredients in this report have discreet fatty chain length name and definition, the actual
ingredients are likely mixtures of different chain lengths, wherein the named length is the primary, or average, length in that
cut. Those ingredients with a cocoyl name are the result of reaction with coconut acid, which has a known composition
of approximately: 0-1% caproic, 5%-9% caprylic, 6%-10% capric, 44%-52% lauric, 13%-19% myristic, 0-1% palmitoleic,
1%-3% stearic, 5%-8% oleic, and trace-2.5% linoleic acid. Accordingly, not only do these alkyl taurate amides share the
same taurate core and similar fatty chain lengths, but many of these ingredients have identical component overlap (eg, there is
likely some sodium methyl lauroyl taurate in sodium ethyl cocoyl taurate (cocoyl means 44%-52% lauroyl) and in sodium
methyl myristoyl taurate (myristoyl likely has some smaller (lauroyl) and longer (palmitoyl) chain lengths therein).
TAURINE
Taurine is a white or colorless crystal powder.15 It has high water solubility and low lipophilicity because of the
zwitterionic properties.
Method of Manufacture
ALKYL TAURATE AMIDES
In general, alkyl taurate amides may be manufactured by reaction of taurine, or a taurate salt, with the appropriate
fatty acid. For example, manufacture of sodium methyl stearoyl taurate may be accomplished by heating triple pressed
stearic acid, sodium methyltaurate solution, and boric acid to 200C while stirring with a subsurface nitrogen purge, distilling
off any water.16 The stirring continues at 195-200C for 6 h at atmospheric pressure and then for 3 h at 100 mmHg vacuum.
The mass is cooled and the resulting product, an off-white waxy solid, is ground to a powder. The resulting product is
reported to be 64.0% sodium methyl stearoyl taurate as active ingredient, 29.5% free fatty acid, 2.5% sodium
N-methyltaurate, and 4.0% other unspecified chemicals. The conversion of sodium methyltaurate using this method was
reported to be greater than 91%. Using coconut fatty acid in place of the triple pressed stearic acid resulted in a conversion of
97%.
In another example, calcium lauroyl taurate was reported to be synthesized by dissolving taurine in a mixture (86:14,
wt/wt) of deionized water and isopropyl alcohol followed by the addition of sodium hydrate. Lauric acid chloride and 48%
aqueous sodium hydrate solution is dropped into the taurine solution for 1h at 40C followed by stirring for 1h at the same
temperature to produce sodium lauroyl taurate. Hydrochloric acid (35%) and an aqueous calcium chloride solution (20%) are
added, and the reaction mixture stirred for 1h still at 40C. The white precipitate is filtered and the cake washed with
deionized water and isopropyl alcohol, then dried.16
TAURINE
Taurine may be produced by a cyclic process of reacting ethylene oxide with sodium bisulfite and ammonium to
obtain sodium taurate.17 Excess ammonia is removed from the reaction mixture, and then sodium taurate is neutralized with
sulfur dioxide or sulfurous acid to recover taurine. Sodium bisulfate is regenerated and is then reacted with ethylene oxide.
Impurities
Sodium methyltaurate is reported to be 87.0% - 96.0% (w/w) pure.11 Impurities are sodium hydroxide and sodium
2-hydroxyethanesulphonate.
USE
Cosmetic
The Panel assesses the safety of cosmetic ingredients based on the expected use of these ingredients in cosmetics.
The Panel reviews data received from the U.S. Food and Drug Administration (FDA) and the cosmetics industry to determine
the expected cosmetic use. The FDA collects data from manufacturers on the use of individual ingredients in cosmetics, by
cosmetic product category, through the FDA Voluntary Cosmetic Registration Program (VCRP). Data from the cosmetic
industry are submitted in response to a survey of the maximum reported use concentrations, by category, conducted by the
Personal Care Products Council (Council).
According to 2015 VCRP survey data, sodium methyl cocoyl taurate is reported to be used in 339 formulations; the
majority of the uses (322) are in rinse-off formulations (Table 4). Most of the ingredients have no reported uses in the
VCRP.
A survey is being conducted by the Council on the concentration of use. When these data are available, they will be
incorporated into this safety assessment.
Sodium methyl cocoyl taurate is reported to be used in 1 baby product and in 140 products that result in exposure to
mucous membranes.
None of the ingredients in this report are restricted from use in any way under the rules governing cosmetic products
in the European Union.18
Non-Cosmetic
SODIUM METHYL OLEOYL TAURATE
Sodium methyl oleoyl taurate may be used as a component of paper and paperboard that comes into contact with dry
food without restriction. It may come into contact with aqueous and fatty foods only as an adjuvant to control pulp
absorbency and pitch content in the manufacturing process.[21CFR176.170; 21CFR176.180] Sodium methyl oleoyl taurate
residues, when used in pesticides for food crops, are exempted from the requirement of a tolerance when used in accordance
with good agricultural practice as inert (or occasionally active) ingredients in pesticide formulations applied to growing crops
or to raw agricultural commodities after harvest.[40CFR180.910] Sodium methyl oleoyl taurate is also exempted from the
requirement of a tolerance when used in accordance with good agricultural practice as inert (or occasionally active)
ingredients in pesticide formulations applied to animals.[40CFR180.930]
TOXICOKINETICS
Absorption, Distribution, Metabolism, and Excretion
OVERVIEW OF TAURINE
Taurine is ubiquitous in high concentrations throughout the animal kingdom (except for protozoans).20 A human
weighing 70 kg consists of up to 70 g of taurine. Taurine plays a part in the regulation of the cardiovascular system, brain,
retina, liver, sperm motility/osmoprotection, muscle, and other general biological activities (for example, osmoregulation and
calcium modulation). In general, taurine exists in cells lacking cell walls in high concentrations and is almost completely
absent from cells having cell walls. In mammals, taurine is particularly high in electrically excitable tissues, especially in
secretory structures.
After ingestion in mammals, taurine is mostly excreted unchanged or in the form of bile salts such as taurocholate.20
Most mammals acquire taurine as an end product of sulfur metabolism (sulfur amino acids/cysteine to cysteine sulfonate to
sulfate and taurine). Mammals are unable to oxidize the sulfur in taurine, to cleave the C-S bond, or to recycle the carbon of
taurine into the general metabolic pool.
TOXICOLOGICAL STUDIES
Single Dose (Acute) Toxicity
Dermal Non-Human
SODIUM METHYL OLEOYL TAURATE
In an acute dermal toxicity assay, sodium methyl oleoyl taurate (100%; 2000 mg/kg) was administered under semi-
occlusion to 10% of the body surface according to the Organization for Economic Cooperation and Development (OECD)
Guideline 402 (Acute Dermal Toxicity) in Wistar rats (n=5/sex13 The test substance was then washed off and the rats were
observed for 14 days. There were no mortalities or clinical signs. At necropsy, there was no specific pathology associated
with the test substance observed, except some residual discoloration of the skin at the test site.
The acute dermal LD 50 of sodium methyl oleoyl taurate was reported to be >2000 mg/kg in rats.21
Oral Non-Human
SODIUM METHYLTAURATE
In an assay conducted according to OECD Guideline 401, the oral LD 50 of sodium methyltaurate in Wistar rats was
reported to be 4670 mg/kg in water (the highest dose tested).11 The test substance was 80%-84% pure. Necropsies showed
unspecified changes to the intestines/gastrointestinal tract, especially in the rats that died before the end of the experiment
(number not specified).
Inhalation
No published acute inhalation toxicity studies were discovered, and no unpublished data were submitted.
Oral Non-Human
SODIUM METHYL OLEOYL TAURATE
When sodium methyl oleoyl taurate (0.662 g/kg ; 10% LD 50 ) was administered by gavage for 6 days/week until 25
doses were administered to albino Harlan mice (n=10), 1 mouse was dead on day 5 and 5 were dead on day 10.22 No more
mice died through the 25th dose.
Inhalation
No published repeated dose inhalation toxicity studies were discovered, and no unpublished data were submitted.
GENOTOXICITY
In Vitro
SODIUM METHYL COCOYL TAURATE
In an Ames test conducted according to OECD Guideline 471 (Bacterial Reverse Mutation Assay) using Salmonella
typhimurium (strains TA1535, TA1537, TA98, and TA100) and Escherichia coli (strain WP2 uvr A) with and without
metabolic activation, sodium methyl cocoyl taurate (5-5000 g/plate in distilled water; 97.7% pure) was not genotoxic.13 The
exposure time was 48 h. There were visible reductions in the growth of the bacterial background lawns of S. typhimurium
strains at 500 g/plate and above. The results of the controls were as expected.
In a genotoxicity assay conducted according to OECD Guideline 487 (In Vitro Mammalian Cell Micronucleus Test)
using human lymphocytes, sodium methyl cocoyl taurate (97.7%) was not genotoxic up to 320 g/mL without metabolic
activation and up to 240 g/mL with metabolic activation when incubated for 4 h.13 When the incubation time was extended
to 20 h without metabolic activation, there were still no genotoxic effects observed. The positive controls had the expected
results; there were no negative controls.
In a mammalian cell gene mutation assay conducted according to OECD Guideline 476 (In vitro Mammalian Cell
Gene Mutation Test) and using mouse lymphoma L5178Y cells, sodium methyl cocoyl taurate (reported to be 97.7% pure)
was not genotoxic up to 100 g/mL without metabolic activation and up to 120 g/mL with metabolic activation when
incubated for 4 h.13 When the incubation time was extended to 24 h without metabolic activation, there were no genotoxic
effects observed up to 80 g/mL. Cytotoxicity was observed in the 4-h exposure at 60 g/mL and above with metabolic
activation and at 50 g/mL and above without metabolic activation. In the 24-h exposure without metabolic activation,
cytotoxicity was observed at 15 g/mL and above. The positive controls had the expected results; there were no negative
controls.
SODIUM METHYLTAURATE
In an Ames test conducted similar to OECD Guideline 471 (Bacterial Reverse Mutation Assay) using S.
typhimurium (strains TA1535, TA1537, TA98 and TA100) with and without metabolic activation, sodium methyltaurate (4-
5000 g/plate) was not genotoxic.11 The results of the controls were as expected.
In Vivo
No published in vivo genotoxicity studies were discovered, and no unpublished data were submitted.
CARCINOGENICITY
Studies
No published carcinogenicity studies were discovered, and no unpublished data were submitted.
Ocular
SODIUM METHYLTAURATE
An ocular irritation assay was conducted of sodium methyltaurate (80%-84% in saline; 100 mg) according to OECD
Guideline 405 (Acute Eye Irritation/Corrosion) in New Zealand White rabbits (n=3).11 The test substance was left in place
for 24 h; the eyes were observed at 1, 24, 48, and 72 h and at 14 and 21 d. The cornea irritation score was below 4 of 4 at all
observation times. The iris irritation scores was between 0 and 1 of 2 up to 72 h; then the irritation was resolved at the next
observation. The conjunctiva irritation score was below 3 of 3 at all observation times and was not fully reversed at 21 d. It
was concluded that sodium methyltaurate caused persistent corneal opacity as well as inflammation of the iris and
conjunctiva resulting in irreversible eye damage.
An ocular irritation assay was conducted of sodium methyltaurate (35%-37% aqueous; 0.1 mL) according to OECD
Guideline 405 in New Zealand White rabbits (n=3).11 The test substance was left in place for 24 h; the eyes were observed at
1, 24, 48, and 72 h and 7 d. The cornea irritation score was between 1 and 4 of 4 at all observation times, and was not fully
reversed by 7 d. The iris irritation scores were between 0 and 1 of 2 up to 72 h; the irritation was resolved by 7 d. The
conjunctiva irritation score was between 2 and 3 of 3 at all observation times and irritation was not fully reversed at 7 d. It
was concluded that sodium methyltaurate caused persistent corneal opacity as well as inflammation of the iris and
conjunctiva resulting in irreversible eye damage.
Sensitization
Dermal Non-Human
SODIUM METHYL COCOYL TAURATE
In a Buehler sensitization assay conducted according to OECD Guideline 406 (Skin Sensitization) in female
Pirbright-White guinea pigs (n=20; control=10), the epicutaneous induction was conducted with sodium methyl cocoyl
taurate at 100% under occlusion and the challenge was conducted at 20% (in water), also under occlusion.13 The challenge
sites were observed at 24 and 48 h after administration. There were no reactions observed during induction or after the
challenge. It was concluded that sodium methyl cocoyl taurate was not sensitizing.
Case Studies
A 53-year-old woman, with a history of itching when having her hair colored, developed pruritus of the scalp
followed by flushing of her entire body, dyspnea, vomiting, and hypotension while having her hair colored.25 She was treated
with intravenous steroids and hydration in the hospital. A skin prick test of the ingredients of the hair dye (1% of the
concentration applied to the hair) showed positive responses to p-aminophenol and sodium methyl oleoyl taurate.
SUMMARY
This is a safety assessment of the available scientific literature relevant to assessing the safety of alkyl taurate
amides and taurate salts as used in cosmetics. The alkyl taurate amides and taurate salts in this report are all structurally
related by having the same taurate core. While the free acid, taurine, is a cosmetic ingredient, it is not included herein
because it functions exclusively as a fragrance and is under the purview of RIFM. These ingredients mostly function as
surfactants cleansing agent.
According to 2015 VCRP survey data, sodium methyl cocoyl taurate is reported to be used in 339 formulations;
most of these uses are in rinse-off formulations. There are no reported uses in the VCRP for most of the ingredients in this
safety assessment.
There were no adverse effects observed from the dermal administration of sodium methyl oleoyl taurate at 100%
(2000 mg/kg) to rats.
There were no deaths during the 14-day observation period after 200 mg/kg of 20% sodium methyl cocoyl
taurate was administered by gavage to rats. Clinical signs included hypoactivity, squatting posture, and coat bristling. The
oral LD 50 for sodium methyl oleoyl taurate was reported to be 6.63 g/kg in mice. The oral LD 50 of sodium methyltaurate in
rats was reported to be 4670 mg/kg, the highest dose tested.
The authors concluded that sodium methyl cocoyl taurate increased the toxicity of N-ammonium thioglycolate when
both were administered to the skin of rabbits compared to N-ammonium thioglycolate alone. The LD 50 of N-ammonium
thioglycolate decreased from >6.5 mg/kg/d to 3.44 mg/kg/d when combined with 3.0-4.0 mg/kg/d sodium methyl cocoyl
taurate.
When 0.662 g/kg sodium methyl oleoyl taurate was administered by gavage 6 days/week for 25 doses to 10 mice, 1
mouse was dead on day 5 and 5 were dead on day 10. No more mice died through day 25.
Sodium methyl cocoyl taurate was not genotoxic in an Ames test up to 5000 g/plate, in a chromosome aberration
assay genotoxic up to 320 g/mL without metabolic activation and up to 240 g/mL with metabolic activation, or in a
mammalian cell gene mutation assay up to 100 g/mL without metabolic activation and up to 120 g/mL with metabolic
activation. Sodium methyltaurate was not genotoxic in an Ames test up to 5000 g/plate.
Sodium methyltaurate at 76%-84% was dermally irritating to rabbits but was not irritating at 35%-37%.
In 2 in vitro skin corrosion assays, sodium methyl cocoyl taurate was not predicted to be irritating. However, a
negative result is not definitive.
Sodium methyl cocoyl taurate at 100% was an ocular irritant to rabbits. In a Draize test of sodium methyl myristoyl
taurate at 10% aqueous, the score was ~2.2 out of 5 in rabbits. Sodium methyltaurate at 80%-84% and 35%-37% caused
persistent corneal opacity as well as inflammation of the iris and conjunctiva resulting in irreversible eye damage. The ocular
irritation score was 2 (out of a possible 4) for sodium methyl oleoyl taurate at 1% administered to the eyes of rabbits.
Sodium methyl cocoyl taurate was not sensitizing at 100% when challenged at 20% to guinea pigs.
A woman developed sensitization to sodium methyl oleoyl taurate after repeatedly dying her hair.
DATA NEEDS
CIR is seeking all information pertaining to the safety of these ingredients in a wide range of areas, including:
Even though there are some data on sodium methyl cocoyl taurate, sodium methyl myristoyl taurate, sodium methyltaurate,
and sodium methyl oleoyl taurate, additional supporting data are desired.
TABLES
Table 1. Definitions, structures, and functions of the ingredients in this safety assessment.(1, CIR Staff)
Ingredient/CAS No. Definition & Structure Function
Simple Taurine Salts
Potassium taurate Potassium taurate is the organic salt that conforms to the formula: Surfactant -
[22890-34-2] cleansing
agent;
surfactant -
[Potassium taurate is the potassium salt of 2-aminoethane-1-sulfonate.] foam booster
Sodium methyltaurate Sodium methyltaurate is the organic compound that conforms to the formula: Skin-
4316-74-9 conditioning
agent -
miscellaneous
[Sodium methyltaurate is the sodium salt of 2-(methylamino)ethane-1-sulfonate.]
Sodium taurate Sodium Taurate is the organic salt that conforms to the formula: Surfactant
[7347-25-3] cleansing
agent;
surfactant
[Sodium Taurate is the sodium salt of 2-aminoethane-1-sulfonate.] foam booster
where RC(O)- represents the fatty acids derived from coconut oil.
[potassium methyl cocoyl taurate is the potassium salt of
2-(N-methylcocamido)ethane-1-sulfonate.*]
Sodium caproyl Sodium caproyl methyltaurate is the sodium salt of the caproic acid amide of N-methyl Surfactant
methyltaurate taurine. It conforms to the formula: cleansing
[20461-70-5] agent
[This is just one example of an iso compound, according to the INCI definition.
Sodium N-isostearoyl methyltaurate is the sodium salt of
2-(N-isooctadecanamido)ethane-1-sulfonate.]
Sodium lauroyl taurate Sodium lauroyl taurate is the organic salt that conforms generally to the formula: Surfactant
70609-66-4 cleansing
agent
[This is just one example of an iso compound, according to the INCI definition.
Sodium methyltaurate isopalmitamide is the sodium salt of
2-(N-isooctadecanamido)ethane-1-sulfonate.]
Sodium methyltaurine cocoyl Sodium methyltaurine cocoyl methyltaurate is the organic salt that conforms to the Surfactant
methyltaurate formula: cleansing
agent;
surfactant
emulsifying
agent
Table 2. Previous safety assessment of component moieties of the ingredients in this safety
assessment.
Maximum
concentration in safety
Ingredients Conclusion (year) assessment Reference
Coconut oil, acid and related ingredients Safe as used (2011) 100% 2,5-7
Oleic acid, lauric acid, myristic acid, stearic acid Safe as used. (2005) > 50%; 43% 3,8
o 13
Boiling Point C 378.6-385.5
Water Solubility g/L @ 20oC & pH 6.4 0.23 13
Potassium taurate
27
Molecular Weight g/mol 163.2372
Sodium methyltaurate
11
Physical Form Solid
11
Color Yellow
33
Molecular Weight g/mol 161.16
33
Density/Specific Gravity 1.21
Table 3. Chemical and physical properties of alkyl taurate amides and taurate
salts.
Property Value Reference
Melting Point oC 160 11
Sodium taurate
12,34
Physical form Solid
35
Molecular Weight g/mol 147.128
Table 4. Frequency of use according to duration and exposure of alkyl taurate amides and taurate salts. The
Council is conducting a survey of the concentration of use for the ingredients added to this report.
Maximum Maximum Maximum Maximum
Concentration Concentration Concentration Concentration
Use type Uses (%) Uses (%) Uses (%) Uses (%)
Potassium taurate Sodium methyltaurate Sodium taurate Calcium laryoyl taurate
Total/range NR NS 2 NS NR NS NR NS
Duration of use
Leave-on NR NS NR NS NR NS NR NS
Rinse-off NR NS 2 NS NR NS NR NS
Diluted for (bath)
NR NS NR NS NR NS NR NS
use
Exposure type
Eye area NR NS NR NS NR NS NR NS
Incidental
NR NS NR NS NR NS NR NS
ingestion
Incidental
NR NS NR NS NR NS NR NS
Inhalation-sprays
Incidental
NR NS NR NS NR NS NR NS
inhalation-powders
Dermal contact NR NS 2 NS NR NS NR NS
Deodorant
NR NS NR NS NR NS NR NS
(underarm)
Hair-noncoloring NR NS NR NS NR NS NR NS
Hair-coloring NR NS NR NS NR NS NR NS
Nail NR NS NR NS NR NS NR NS
Mucous
NR NS NR NS NR NS NR NS
Membrane
Baby NR NS NR NS NR NS NR NS
Table 4. Frequency of use according to duration and exposure of alkyl taurate amides and taurate salts. The
Council is conducting a survey of the concentration of use for the ingredients added to this report.
Maximum Maximum Maximum Maximum
Concentration Concentration Concentration Concentration
Use type Uses (%) Uses (%) Uses (%) Uses (%)
Magnesium methyl Potassium methyl cocoyl Sodium caproyl
cocoyl taurate Potassium cocoyl taurate taurate methyltaurate
Total/range NR NS NR NS NR NS NR NS
Duration of use
Leave-on NR NS NR NS NR NS NR NS
Rinse-off NR NS NR NS NR NS NR NS
Diluted for (bath)
NR NS NR NS NR NS NR NS
use
Exposure type
Eye area NR NS NR NS NR NS NR NS
Incidental
NR NS NR NS NR NS NR NS
ingestion
Incidental
NR NS NR NS NR NS NR NS
Inhalation-sprays
Incidental
NR NS NR NS NR NS NR NS
inhalation-powders
Dermal contact NR NS NR NS NR NS NR NS
Deodorant
NR NS NR NS NR NS NR NS
(underarm)
Hair-noncoloring NR NS NR NS NR NS NR NS
Hair-coloring NR NS NR NS NR NS NR NS
Nail NR NS NR NS NR NS NR NS
Mucous
NR NS NR NS NR NS NR NS
Membrane
Baby NR NS NR NS NR NS NR NS
Sodium methyl stearoyl Sodium methyltaurate Sodium methyltaurine Sodium taurine cocoyl
taurate isopalmitamide cocoyl methyltaurate methyltaurate
Total/range 8 NS NR NS NR NS NR NS
Duration of use
Leave-on 8 NS NR NS NR NS NR NS
Rinse-off NR NS NR NS NR NS NR NS
Diluted for (bath)
NR NS NR NS NR NS NR NS
use
Exposure type
Eye area NR NS NR NS NR NS NR NS
Incidental
NR NS NR NS NR NS NR NS
ingestion
Incidental
4a; 4b NS NR NS NR NS NR NS
Inhalation-sprays
Incidental
NR NS NR NS NR NS NR NS
inhalation-powders
Dermal contact 8 NS NR NS NR NS NR NS
Deodorant
NR NS NR NS NR NS NR NS
(underarm)
Hair-noncoloring NR NS NR NS NR NS NR NS
Hair-coloring NR NS NR NS NR NS NR NS
Nail NR NS NR NS NR NS NR NS
Mucous
NR NS NR NS NR NS NR NS
Membrane
Baby NR NS NR NS NR NS NR NS
NR = Not Reported; NS = Not Surveyed; Totals = Rinse-off + Leave-on Product Uses.
Note: Because each ingredient may be used in cosmetics with multiple exposure types, the sum of all exposure type uses may not equal the
sum total uses.
a
It is possible these products may be sprays, but it is not specified whether the reported uses are sprays.
b
Not specified whether a powder or a spray, so this information is captured for both categories of incidental inhalation.
REFERENCES
1. Nikitakis, J and Breslawec HP. International Cosmetic Ingredient Dictionary and Handbook. 15 ed. Washington, DC: Personal Care Products
Council, 2014.
2. Andersen, FA. Annual review of cosmetic ingredient safety assessments 2002/2003. International Journal of Toxicology. 2005;24(Suppl. 1):1-
102.
3. Andersen, FA. Annual review of cosmetic ingredient safety assessments - 2004/2005. International Journal of Toxicology. 2006;26(Suppl. 2):1-
89.
4. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Marks JG, Shank RC, Slaga TJ, Snyder PW, and Andersen FA. Final report of the
amended safety assessment of myristic acid and its salts and esters as used in cosmetics. Int J Toxicol. 2010;29(Suppl 3):162-186.
5. Bergfeld, WF, Belsito, DV, Hill, RA, Klaassen, CD, Liebler, DC, Marks Jr, JG, Shank, RC, Slaga, TJ, Snyder, PW, Andersen, FA, Burnett, CL,
and Fiume, M. Final report: Plant-derived fatty acid oils as used in cosmetics. Washington, DC, Cosmetic Ingredient Review. 2011.
pp. 1-100.
6. Burnett, CL, Bergfeld, WF, Belsito, DV, Klaassen, CD, Marks Jr, JG, Shank, RC, Slaga, TJ, Snyder, PW, and Andersen, FA. Final report on the
safety assessment of Cocos nucifera (coconut) oil and related ingredients. International Journal of Toxicology. 2011;30(Suppl 1):5S-
16S.
7. Elder, RL. Final report on the safety assesment of coconut oil, coconut acid, hydrogenated coconut acid, and hydrogenated coconut oil. Journal of
the American College of Toxicology. 1986;5(3):103-121.
8. Elder, RL. Final report on the safety assessment of oleic acid, lauric acid, palmitic acid, myrisitic acid, and stearic acid. Journal of the American
College of Toxicology. 1987;6(3):321-401.
9. Elder, RL. Final report on the safety assessment of isoproyl linoleate. Journal of the American College of Toxicology. 1992;11(1):51-56.
10. Fiume, M, Bergfeld, WF, Belsito, DV, Hill, R, Klaassen, CD, Liebler, D, Marks Jr, JG, Shank, RC, Slaga, TJ, Snyder, PW, and Andersen, FA.
Final report on stearyl heptanoate and related stearyl alkanoates as used in cosmetics. International Journal of Toxicology.
2012;31(Suppl. 2):141S-146S.
11. European Chemicals Agency (ECHA). Sodium N-methyltaurinate. http://echa.europa.eu. Last Updated 2015. Date Accessed 3-10-2015.
12. European Chemicals Agency (ECHA). Sodium taurinate. http://echa.europa.eu. Last Updated 2015. Date Accessed 3-10-2015.
13. European Chemicals Agency (ECHA). Sodium methyl cocoyl taurate. http://echa.europa.eu. Last Updated 2015. Date Accessed 3-10-2015.
14. Nonomura, Yoshimune, Kurita, Kenkou, Kashimoto, Akio, Hotta, Hajime, Kaneko, Yohei, and Iitaka, Kazuhiro. The internal structure and
tribology of calcium lauroyl taurate. Chemistry Letters. 2002;31(2):216-217.
15. O'Neil, MJ. The Merck Index - An encyclopedia of chemicals, drugs, and biologicals. Cambridge, UK: Royal Society of Chemistry, 2013.
17. Hu, S; inventor. Cyclic process for the production of taurine. US 8,609,890. 12-17-2013.
18. European Commission. CosIng database; following Cosmetic Regulation No. 1223/2009. http://ec.europa.eu/consumers/cosmetics/cosing/. Last
Updated 2014. Date Accessed 4-21-0015.
19. European Parliment and of Council and Regulations (EC). Commision regulations (EC). Official Journal of the European Union. 11-30-
2009;314:36-42.
21. Solvay. Safety Data Sheet: GEROPON T 77 [pamphlet]. Santo Andr, So Paulo: Rhodia Poliamida e Especialidades Ltda; 2013.
22. Hopper, SS, Hulpieu, HR, and Cole, VV. Some toxicological properties of surface-active agents. Journal of the American Parmaceutical
Association. 1949;38(8):428-432.
23. Gershbein, LL. Percutaneous toxicity of thioglycolate mixtures in rabbits. Journal of Pharmaceutical Sciences. 1979;68(10):1230-1235.
24. Okahata, Yoshio and Ebato, Hiroshi. Absorption behaviors of surfactant molecules on a lipid-coated quartz-crystal microbalance. An alternative
to eye-irritant tests. Analytical Chemistry. 1991;63(3):203-207.
25. Uehara, S, Inomata, N, Suzuki, A, Matsuura, M, and Aihara, M. Severe contact urticarial syndrome due to oxidative hair dye containing para-
aminophenol and sodium-methyl-oleoyl-taurate. The Journal of Dermatology. 2014;41(6):560-561.
26. Guidechem. Calcium lauroyl taurate (CAS No. 138705-25-6). http://www.guidechem.com/reference/dic-462936.html. Last Updated 2010.
29. Nikko Chemicals Col, Ltd. Material safety data sheet, Sodium Methyl Lauroyl Taurate [pamphlet]. Tokyo, Japan: Barnet Products Corp.; 2015.
30. National Center for Biotechnology Information. PubChem Compound Database; CID
23664339. http://pubchem.ncbi.nlm.nih.gov/compound/23664339. Last Updated 2015.
32. Guidechem. Chemical Trading Guide: CAS No. 3737-55-1 (Ethanesulfonic acid,2-[methyl(1-oxohexadecyl)amino]-, sodium salt (1:1)
). http://www.guidechem.com/cas-373/3737-55-1.html. Last Updated 2015.
33. Chemical Book. Chemical Book, N-methyltaurine sodium salt. http://www.chemicalbook.com/CAS_4316-74-9.htm. Last Updated 2010.
34. Biosynth Chemistry & Biology. Safety data sheet: Sodium taurinate. 2014. pp.1-4.
35. Chemical Book. Chemical Book, Taurine sodium. http://www.chemicalbook.com/ChemicalProductProperty_EN_CB4841014.htm. Last Updated
2010.